Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Plexus Corp (NASDAQ: PLXS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Plexus files periodic and current reports as a Wisconsin corporation with Commission File Number 001-14423.
Among the key documents available are current reports on Form 8-K, which Plexus uses to furnish press releases announcing quarterly and annual financial results. These filings typically include information on revenue, operating margin, earnings per share, non-GAAP performance measures, return on invested capital, free cash flow and other financial metrics, as well as commentary on business conditions and program wins.
Through this page, users can track how Plexus reports its results for fiscal quarters and years, including references to its geographic segments in the Americas, Asia-Pacific and Europe, Middle East and Africa regions, and its focus on Aerospace/Defense, Healthcare/Life Sciences and Industrial market sectors. Filings also confirm corporate details such as state of incorporation and principal corporate location.
Stock Titan enhances these filings with AI-powered summaries that highlight the most important points from lengthy documents, helping readers quickly understand the implications of each report. Real-time updates from the SEC’s EDGAR system, along with structured access to forms such as 8-K and other periodic reports, make it easier to review Plexus’ regulatory history and monitor ongoing disclosures related to PLXS.
Plexus Corp (PLXS) reported an amended insider transaction. The company’s Chairman of the Board and Director filed a Form 4/A correcting the number of restricted stock units granted on 02/03/2025 to 1,370 RSUs under the Plexus Corp. 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of common stock and vests on 02/03/2026.
Following the reported transaction, the filing lists 1,370 derivative securities beneficially owned, held directly. The amendment states it was filed to correct the number of RSUs granted.
Plexus Corp (PLXS) filed a Form 4/A amending an equity award to a director. The filing corrects the reported grant to 1,370 restricted stock units under the Plexus Corp. 2024 Omnibus Incentive Plan, with vesting on February 3, 2026.
The transaction date is February 3, 2025, and the reported ownership is direct. Each RSU represents a contingent right to receive one share of Plexus common stock.
Plexus Corp (PLXS) reported insider activity by its President & CEO and Director, Todd P. Kelsey. On 10/29/2025, he disposed of 5,000 shares of common stock under transaction code G, which denotes a bona fide gift. Following this transaction, he beneficially owned 64,214 shares, held directly.
This reflects a charitable or personal transfer rather than a market sale, as indicated by the gift code and footnote stating the shares “were given as a bona fide gift.”
Plexus Corp. (PLXS) disclosed an insider transaction on Form 4. Exec. VP & CFO Patrick J. Jermain sold 1,998 shares of common stock at $142.8 on 10/27/2025.
Following the sale, he beneficially owned 18,961 shares directly. He also held 3,719 shares indirectly through the company’s 401(k) Retirement Plan, based on the plan trustee’s most recent report.
Plexus Corp. (PLXS) filed an 8-K reporting earnings timing. The company announced results for its fiscal fourth quarter and year ended September 27, 2025, and furnished a related press release.
The press release is included as Exhibit 99.1, dated October 22, 2025. Common stock trades on the Nasdaq Global Select Market under PLXS.
Plexus Corp (PLXS) insider Todd P. Kelsey, who serves as President & CEO and a director, reported a sale of 1,500 shares of common stock on 10/01/2025 at a price of $143.70 per share. The filing shows 69,214 shares remain beneficially owned by the reporting person after the transaction. The Form 4 notes the shares were sold under a Rule 10b5-1 trading plan adopted on August 16, 2024, and the filing was signed via attorney-in-fact on 10/02/2025.
Angelo M. Ninivaggi Jr., Executive Vice President, Chief Administrative Officer, General Counsel and Secretary of Plexus Corp (PLXS), reported a non‑derivative disposition on 09/04/2025. The filing shows 1,100 shares of Plexus common stock were disposed of under Transaction Code G and the form notes those shares were given as a bona fide gift. After the reported transaction, Mr. Ninivaggi beneficially owned 23,395 shares.
The Form 4 was signed on behalf of the reporting person by an attorney‑in‑fact on 09/05/2025. The report is a single‑person filing and contains no derivative transactions or price information for the gift beyond the coding and resulting beneficial ownership figure.
Todd P. Kelsey, President & CEO and a director of Plexus Corp (PLXS), reported a sale of company stock under a pre-established 10b5-1 plan. On 09/02/2025 he disposed of 1,500 shares of Plexus common stock at $134.54 per share. After the reported sale, Mr. Kelsey beneficially owned 70,714 shares, held directly. The filing states the transactions were made pursuant to a Rule 10b5-1 plan adopted on August 16, 2024, and the Form 4 was signed on 09/03/2025 by an attorney-in-fact.
Plexus Corp (PLXS) director Karen M. Rapp reported a sale of common stock under a pre-existing Rule 10b5-1 plan. The filing shows a disposition of 500 shares on 08/29/2025 at a reported price of $139 per share. The sale was made pursuant to a plan adopted on February 28, 2024. After the reported transaction Ms. Rapp is shown as beneficially owning 8,865 shares of Plexus common stock, held directly. The Form 4 was signed via attorney-in-fact on 09/02/2025 and was filed as a single reporting person filing.
Plexus Corp (PLXS) Form 144 notice shows a proposed sale of 4,500 common shares through Robert W. Baird on 09/02/2025, with an aggregate market value of $628,290. The shares were acquired on 01/27/2023 upon vesting of restricted stock units and were paid as compensation. The filing reports 26,986,726 shares outstanding. It also discloses three prior sales by the same person of 1,500 shares each on 06/02/2025, 07/01/2025 and 08/01/2025 with gross proceeds of $194,805.45, $201,765 and $188,445, respectively.